NTES [NetEase] 6-K: Contact for Media and Investors: Cassia Curran NetEase,

[Contact for Media and Investors: Cassia Curran NetEase, Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports First Quarter 2015 Unaudited Financial Results (Beijing — May 13, 2015) — NetEase, Inc. (NASDAQ: NTES), one of China’s leading Internet and online game services providers, today announced its unaudited financial results for the first quarter ended] [FORM 6-K NETEASE, INC. 26/F, SP Tower D Form 20-F x Form 40-F o o o NETEASE, INC. Form 6-K TABLE OF CONTENTS Page]

By | 2016-03-26T14:15:00+00:00 May 14th, 2015|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Resignation of an Independent Director HONG KONG, China, May 14, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that Mr. Julian J. Wolhardt, one of the Company’s independent directors, has resigned] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description 99.1]

By | 2016-03-27T08:52:31+00:00 May 14th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities BEIJING, May 14, 2014 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company received site inspection notification for the commercial production facilities of its EV71 vaccine candidate from the China Food and Drug Administration (CFDA). This notification represents a significant step] []

By | 2016-03-16T06:30:07+00:00 May 14th, 2015|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Resignation of an

[China Cord Blood Corporation Announces Resignation of an Independent Director HONG KONG, China, May 14, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that Mr. Julian J. Wolhardt, one of the Company’s independent directors, has resigned] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description 99.1]

By | 2016-03-27T08:53:44+00:00 May 14th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar